Bayer AG (ETR: BAYN, FRA: BAYN, OTCMKTS: BAYRY), a leading German life sciences company, announced last week the opening of a new life sciences incubator in Shanghai, named Bayer Co.Lab Shanghai. The incubator is located in the Shanghai Innovation (SH-INNO) Park within the Zhanghiang biopharma cluster and is part of Bayer’s global network of incubators, which includes locations in Cambridge (US), Kobe (Japan), and Berlin (Germany).
The Shanghai facility is designed to promote open collaboration within the local biotech ecosystem, with a specific focus on cell and gene therapies. The Bayer Co.Lab program is intended to provide early-stage entrepreneurs with access to R&D expertise, manufacturing capabilities, and partnership opportunities, as well as to Bayer’s global networks. Distinctively, the benefits are offered without any obligations, allowing companies to retain their independence while leveraging Bayer’s internal resources.- Flcube.com
